A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...
Researchers from Children's Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ultra-rare genetic disorder that can cause ...
Philadelphia and Gordonville, PA, August 12, 2025 – Researchers from Children’s Hospital of Philadelphia (CHOP) and the Clinic for Special Children found that complement factor I (CFI) deficiency, an ...
Credit: Getty Images. CHAPLE disease is a rare genetic disorder caused by mutations in the CD55 gene. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results